Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3 Suppl
|
| pubmed:dateCreated |
1990-9-5
|
| pubmed:abstractText |
Evidence suggests that generalized anxiety disorder (GAD) has a fairly chronic course marked by significant long-term distress and comorbidity. Research has focused on short-term treatment of GAD, and long-term outcome studies after either short- or long-term treatment have been relatively neglected. The authors discuss the benefits and risks of various drug and nondrug therapies used in the long-term management of generalized anxiety disorder and suggest avenues for future research.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0271-0749
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
10
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
101S-110S
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:1973934-Anti-Anxiety Agents,
pubmed-meshheading:1973934-Anxiety Disorders,
pubmed-meshheading:1973934-Benzodiazepines,
pubmed-meshheading:1973934-Buspirone,
pubmed-meshheading:1973934-Chronic Disease,
pubmed-meshheading:1973934-Follow-Up Studies,
pubmed-meshheading:1973934-Humans,
pubmed-meshheading:1973934-Long-Term Care
|
| pubmed:year |
1990
|
| pubmed:articleTitle |
The clinical course and long-term management of generalized anxiety disorder.
|
| pubmed:affiliation |
University of Pennsylvania, Philadelphia.
|
| pubmed:publicationType |
Journal Article,
Review
|